<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200818048448N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-06-08</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of two upper limb physical restraint type on the clinical outcomes of children under mechanical ventilation</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of two upper limb physical restraint type on the clinical outcomes of children under mechanical ventilation: A crossover randomized clinical trial study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-06-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>48</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60021</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Crossover, Purpose: Other, Randomization description: Eligible children will be selected by available sampling method and will be randomly divided into two groups A and B by using Rand List software. The random sequence created will be covered using matte envelopes, and the envelopes will be given to the researcher in order of number, and after opening the envelope, the child's group will be determined, Blinding description: Participants in this study are children who, due to age and clinical condition, will not have real knowledge of the type of intervention performed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>agitation sedation level.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: For group A, first wrist restraint will be done for two hours and then elbow restraint will be done for two hours. Due to the physical restraint performed routinely and to eliminate the effect of restraint, before the intervention, a period of 15 minutes will be considered as a wash out period and the child will be observed by the executive researcher under continuous and direct observation and without restraint. During this time, the researcher will prevent the child from trying to pull the equipment by keeping the limb calm. To restrain the wrist, medical gauze three to five centimeters wide (depending on the child's body) will be used, inside which a cotton roll will be placed. A roll of gauze and cotton is wrapped around the wrist and a long strip of gauze is tied from one end around the roll and from the other end to the bed in the form of the number eight. To prevent pressure on the limb, a distance of one finger (index finger) will be considered between the gas roll and the skin. To apply elbow restraint, two splints with pads, one below and one on the elbow joint, will be used. Then the upper part of the splints on the arm side and the lower part of the splints on the forearm side will be closed using two separate gas strips. In this way, the gas strip is wrapped around the splints and limbs and will be fastened on the upper splint with a simple knot. To prevent pressure on the limb, a distance of one finger (index finger) will be considered between the gas strip and the skin. The size of the splints used will be chosen based on the child's body so that it covers the upper and lower thirds of the elbow joint. Intervention 2: Intervention group: For group B, after a 15-minute wash-out time, first the elbow is restrained for two hours and then the wrist is restrained for two hours. The method of applying wrist and elbow restraint will be the same as the method applied in group A intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Study protocol
Informed consent form

When:
The access time will start 6 months after the results are published.

To whom:
The data will only be available to researchers working at academic institutions.

Conditions:
Researchers working in academic institutions are allowed to request documentation.

Where to obtain:
Refer to the person responsible for the general response of the trial.

How to obtain:
The request is sent to the person in charge of the trial and with the coordination of the research vice chancellor of the university, documents will be sent.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahni Rahkar Farshi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, South Shariati Ave, Tabriz, Iran</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>rahkarfarshim@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahni Rahkar Farshi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, South Shariati Ave. Tabriz, Iran</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>+98 41 3479 6770</telephone>
        <email>rahkarfarshim@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children aged 1 to 5 years
Being hospitalized in the pediatric intensive care unit
Being under mechanical ventilation
Physician order to use physical restraint in the upper limb
The consent of the child's parents</inclusion_criteria>
      <agemin>1 year</agemin>
      <agemax>5 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Existence of intra venous line in both upper limbs
Instability of the child's physiological condition before the intervention
Children with hemiplegia, extensive hematoma, history of surgery or trauma in the restrained limb
Children with casts or splints in restrained limbs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For group A, first wrist restraint will be done for two hours and then elbow restraint will be done for two hours. Due to the physical restraint performed routinely and to eliminate the effect of restraint, before the intervention, a period of 15 minutes will be considered as a wash out period and the child will be observed by the executive researcher under continuous and direct observation and without restraint. During this time, the researcher will prevent the child from trying to pull the equipment by keeping the limb calm. To restrain the wrist, medical gauze three to five centimeters wide (depending on the child's body) will be used, inside which a cotton roll will be placed. A roll of gauze and cotton is wrapped around the wrist and a long strip of gauze is tied from one end around the roll and from the other end to the bed in the form of the number eight. To prevent pressure on the limb, a distance of one finger (index finger) will be considered between the gas roll and the skin. To apply elbow restraint, two splints with pads, one below and one on the elbow joint, will be used. Then the upper part of the splints on the arm side and the lower part of the splints on the forearm side will be closed using two separate gas strips. In this way, the gas strip is wrapped around the splints and limbs and will be fastened on the upper splint with a simple knot. To prevent pressure on the limb, a distance of one finger (index finger) will be considered between the gas strip and the skin. The size of the splints used will be chosen based on the child's body so that it covers the upper and lower thirds of the elbow joint.</i_keyword>
      <i_keyword>Intervention group: For group B, after a 15-minute wash-out time, first the elbow is restrained for two hours and then the wrist is restrained for two hours. The method of applying wrist and elbow restraint will be the same as the method applied in group A intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Erythema. Timepoint: Measurements before the intervention will be reviewed and recorded after the initial cleansing period and before the intervention begins. Measurement during the intervention will be done one hour after the start of the intervention and measurement after the intervention will be performed immediately after the end of the two hours of the intervention. Method of measurement: clinician erythema assessment.</prim_outcome>
      <prim_outcome>Edema of the hand. Timepoint: Measurements before the intervention will be reviewed and recorded after the initial cleansing period and before the intervention begins. Measurement during the intervention will be done one hour after the start of the intervention and measurement after the intervention will be performed immediately after the end of the two hours of the intervention. Method of measurement: Figure-of-Eight Method of Measuring Hand.</prim_outcome>
      <prim_outcome>Palm temperature. Timepoint: Measurements before the intervention will be reviewed and recorded after the initial cleansing period and before the intervention begins. Measurement during the intervention will be done one hour after the start of the intervention and measurement after the intervention will be performed immediately after the end of the two hours of the intervention. Method of measurement: Digital thermometer.</prim_outcome>
      <prim_outcome>Radial pulse. Timepoint: Measurements before the intervention will be reviewed and recorded after the initial cleansing period and before the intervention begins. Measurement during the intervention will be done one hour after the start of the intervention and measurement after the intervention will be performed immediately after the end of the two hours of the intervention. Method of measurement: Manually count the number of radial pulses per minute.</prim_outcome>
      <prim_outcome>Agitation and sedation. Timepoint: Measurements before the intervention will be reviewed and recorded after the initial cleansing period and before the intervention begins. Measurement during the intervention will be done one hour after the start of the intervention and measurement after the intervention will be performed immediately after the end of the two hours of the intervention. Method of measurement: Richmond Agitation-Sedation Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-12</approval_date>
        <contact_name>Ethics committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Faculty of Nursing and Midwifery, South Shariati Ave. Tabriz, Iran Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
